loadpatents
name:-0.0076520442962646
name:-0.004796028137207
name:-0.0015201568603516
Trani; Giancarlo Patent Filings

Trani; Giancarlo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Trani; Giancarlo.The latest application filed is for "benzoxazinone derivatives and analogues thereof as modulators of tnf activity".

Company Profile
1.7.7
  • Trani; Giancarlo - Abingdon GB
  • Trani; Giancarlo - Harlow GB
  • Trani; Giancarlo - Essex GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity
Grant 10,287,299 - Brace , et al.
2019-05-14
Benzoxazinone Derivatives and Analogues Thereof as Modulators of TNF Activity
App 20180134728 - Brace; Gareth Neil ;   et al.
2018-05-17
5,6,7,8-tetrahydroimidazo[1,2-A]pyrazine derivatives as P2X7 modulators
Grant 8,513,248 - Dean , et al. August 20, 2
2013-08-20
5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazine derivatives as P2X7 modulators
Grant 8,501,946 - Dean , et al. August 6, 2
2013-08-06
5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine Derivatives As P2x7 Modulators
App 20120172366 - Dean; David Kenneth ;   et al.
2012-07-05
5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
App 20120157436 - Dean; David Kenneth ;   et al.
2012-06-21
Indazoles used to treat estrogen receptor beta mediated disorders
Grant 7,960,563 - Johnson , et al. June 14, 2
2011-06-14
Compounds
Grant 7,956,083 - Johnson , et al. June 7, 2
2011-06-07
Compounds
App 20100324106 - Johnson; Christopher Norbert ;   et al.
2010-12-23
Indazoles Used To Treat Estrogen Receptor Beta Mediated Disorders
App 20100087502 - Johnson; Christopher Norbert ;   et al.
2010-04-08
Novel Compounds
App 20080058391 - Johnson; Christopher Norbert ;   et al.
2008-03-06
3-((Hetero)arylsulfonyl)-8-'(aminoalkyl)oxyquinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
App 20070191345 - Ahmed; Mahmood ;   et al.
2007-08-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed